← Leaderboards
Kazim A Sheikh
University Of Texas Hlth Sci Ctr Houston
$11,409,209
Attributed
$11,409,209
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $865.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,409,209 · 8
By mechanism
R01$10,031,636 · 4
R21$1,232,500 · 3
P41$145,073 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Axon”
- Stephen M Strittmatter · Yale University$50,437,798
- Z Josh Huang · Cold Spring Harbor Laboratory$35,399,590
- Joshua R Sanes · Washington University$23,908,727
- Hong-Wei Dong · University Of California Los Angeles$23,839,698
- Jeffrey D Milbrandt · Washington University$23,620,454
- W. Dalton Dalton Dietrich · University Of Miami School Of Medicine$22,529,087
Research focus
AxonGangliosidesNeuropathyInjuryPeripheral NervesAcuteAntibodiesNerveMediatingImmuneAnimal ModelRecoveryNerve FibersSpecificityAffectAutoimmune ProcessNerve InjuryAutoimmune ResponsesMultiple SclerosisNatural RegenerationParalysedGuillain-Barre SyndromeAxon RegenerationInjured
Grant awards (38)
Modulation of CSF1R Signaling to Treat Inflammatory Neuropathies$512,221
R01 · FY2025 · NS · contact PI
Modulation of CSF1R Signaling to Treat Inflammatory Neuropathies$569,135
R01 · FY2024 · NS · contact PI
Blockade of colony stimulating factor 1 receptor to reduce inflammatory nerve injury$429,000
R21 · FY2021 · NS · contact PI
Antibody based neuronal and axonal delivery vector for enzyme delivery in GM2 gangliosidosis$423,500
R21 · FY2019 · NS · contact PI
Biologic Effects of Anti-Ganglioside Antibodies$332,500
R01 · FY2018 · NS · contact PI
Biologic Effects of Anti-Ganglioside Antibodies$332,500
R01 · FY2017 · NS · contact PI
Pathogenesis of Anti-ganglioside Antibody-Mediated Neuropathies$332,500
R01 · FY2016 · NS · contact PI
Biologic Effects of Anti-Ganglioside Antibodies$332,500
R01 · FY2016 · NS · contact PI
Pathogenesis of Anti-ganglioside Antibody-Mediated Neuropathies$332,500
R01 · FY2015 · NS · contact PI
Biologic Effects of Anti-Ganglioside Antibodies$332,500
R01 · FY2015 · NS · contact PI
Modulation of FcRn: A strategy to prevent autoantibody-mediated nerve injury$190,000
R21 · FY2015 · NS · contact PI
Biologic Effects of Anti-Ganglioside Antibodies$332,500
R01 · FY2014 · NS · contact PI
Pathogenesis of Anti-ganglioside Antibody-Mediated Neuropathies$329,174
R01 · FY2014 · NS · contact PI
Modulation of FcRn: A strategy to prevent autoantibody-mediated nerve injury$190,000
R21 · FY2014 · NS · contact PI
Non-Invasive Imaging to Quantify Peripheral Nerve Injury and Repair in Clinic$500,170
R01 · FY2013 · NS · contact PI
Pathogenesis of Anti-ganglioside Antibody-Mediated Neuropathies$320,863
R01 · FY2013 · NS · contact PI
Non-Invasive Imaging to Quantify Peripheral Nerve Injury and Repair in Clinic$520,887
R01 · FY2012 · NS · contact PI
Pathogenesis of Anti-ganglioside Antibody-Mediated Neuropathies$332,500
R01 · FY2012 · NS · contact PI
Non-Invasive Imaging to Quantify Peripheral Nerve Injury and Repair in Clinic$543,784
R01 · FY2011 · NS · contact PI
Biologic effects of anti-ganglisiode antibodies$321,563
R01 · FY2011 · NS · contact PI
Biologic effects of anti-ganglisiode antibodies$324,844
R01 · FY2010 · NS · contact PI
Pathogenesis of anti-ganglioside antibody-mediated neuropathies$299,917
R01 · FY2010 · NS · contact PI
Biologic effects of anti-ganglisiode antibodies$328,125
R01 · FY2009 · NS · contact PI
Pathogenesis of anti-ganglioside antibody-mediated neuropathies$306,286
R01 · FY2009 · NS · contact PI
Biologic effects of anti-ganglisiode antibodies$327,306
R01 · FY2008 · NS · contact PI
Pathogenesis of anti-ganglioside antibody-mediated neuropathies$287,371
R01 · FY2008 · NS · contact PI
Pathogenesis of anti-ganglioside antibody-mediated neuropathies$73,388
R01 · FY2008 · NS · contact PI
Pathogenesis of anti-ganglioside antibody-mediated neuropathies$360,576
R01 · FY2007 · NS · contact PI
Biologic effects of anti-ganglisiode antibodies$358,750
R01 · FY2007 · NS · contact PI
Experimental models of Acute Motor Axonal Neuropathy (AM$271,819
R01 · FY2005 · NS
Experimental models of Acute Motor Axonal Neuropathy (AM$271,819
R01 · FY2004 · NS
Experimental models of Acute Motor Axonal Neuropathy (AM$271,819
R01 · FY2003 · NS
Experimental models of Acute Motor Axonal Neuropathy (AM$271,819
R01 · FY2002 · NS
LOCALIZATION OF GAL(BL 3) GALNAC BEARING GLYCOCONJUGATES IN RAT PERIPHERAL NERVE$0
P41 · FY2002 · RR
LOCALIZATION OF GAL(BL 3) GALNAC BEARING GLYCOCONJUGATES IN RAT PERIPHERAL NERVE$106,600
P41 · FY2001 · RR
LOCALIZATION OF GAL(BL 3) GALNAC BEARING GLYCOCONJUGATES IN RAT PERIPHERAL NERVE$0
P41 · FY2001 · RR
LOCALIZATION OF GAL(BL 3) GALNAC BEARING GLYCOCONJUGATES IN RAT PERIPHERAL NERVE$0
P41 · FY2001 · RR
LOCALIZATION OF GAL(BL 3) GALNAC BEARING GLYCOCONJUGATES IN RAT PERIPHERAL NERVE$38,473
P41 · FY2000 · RR